Brief: CytomX Therapeutics Q3 Revenue USD 5.963 Million Vs. IBES Estimate USD 11.6 Million
06/11/2025 21:10
Nov 06 (Reuters) - CytomX Therapeutics Q3 operating expenses USD 21.731 million. Q3 operating income USD -15.768 million Q3 net income USD -14.229 million Q3 cash & investments USD 143.6 million
Recent news on CytomX Therapeutics
See all newsCytomX Q2 revenue misses, partly hurt by lower research activities in the Astellas collaboration
CytomX Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Cytomx Therapeutics Announces Appointment Of Charles Fuchs, M.D., M.P.H., To The Board Of Directors
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway